Geosearch / Live Stats / Bug Report / FAQ / About LinkedCT

1 trial with official title Phase II Trial of Velcade (Bortezomib) in Combination With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly-diagnosed Glioblastoma Multiforme